PEG-Functionalized Nanoparticles for Stable Multi-Agent Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nanoparticles for drug delivery and diagnostics face issues such as poor stability, single-drug payloads, complex treatments, and cumbersome preparation processes, limiting their effectiveness and efficiency.
Innovation Solution
Development of PEG-functionalized nanoparticles with a hydrophobic core and hydrophilic outer layer, formed through amphiphilic compounds and hydrophobic polymers, which are stable in aqueous solutions and can encapsulate various functional agents, allowing for targeted drug delivery and diagnostics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional nanoparticles are used for drug delivery, then they can deliver drugs to target tissue, but they exhibit poor stability during delivery
Solution Approach 1:
The patent uses composite materials by combining hydrophobic polymer cores with hydrophilic PEG shells to create amphiphilic nanoparticle structures. This composite approach resolves the stability contradiction by integrating materials with complementary properties: the hydrophobic core provides structural integrity and drug loading capacity, while the hydrophilic PEG shell provides colloidal stability and resistance to protein adsorption in biological fluids.
Solution Approach 2:
The nanoparticle structure implements local quality by creating distinct regions with different properties: a hydrophobic interior region for drug encapsulation and a hydrophilic exterior region for stability in aqueous environments. This spatial differentiation of material properties allows the particle to simultaneously maintain structural integrity and colloidal stability during drug delivery.
2Adaptability or versatility
If single-drug payloads are used in nanoparticles, then preparation is simpler, but therapeutic effectiveness is limited
Solution Approach 1:
The patent applies universality by designing a nanoparticle platform with a generic hydrophobic polymer core that can encapsulate various types of hydrophobic drugs, imaging agents, or therapeutic molecules. The standardized PEGylated core structure serves as a universal carrier that can be loaded with different functional payloads, enabling one platform to perform multiple therapeutic and diagnostic functions without requiring fundamentally different nanoparticle designs for each application.
3Adaptability or versatility
If complex diagnostic and treatment combinations are implemented, then therapeutic effectiveness improves, but preparation processes become cumbersome
Solution Approach 1:
The patent merges multiple therapeutic and diagnostic functions into a single nanoparticle formulation by co-encapsulating different functional agents (e.g., chemotherapeutic drugs, imaging dyes, or photodynamic therapy agents) within the same hydrophobic core. This consolidation allows combination therapy and theranostic applications to be achieved through a single preparation process rather than requiring separate formulation steps for each component, thereby maintaining ease of manufacture while enhancing therapeutic versatility.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanoparticles exhibit high encapsulation efficiency, stability, and adjustable drug release rates, enabling effective targeted drug delivery and diagnostics with improved stability and ease of manufacturing.
Implementation Method 1
the self-assembly of PEG-L-G amphiphilic molecules which form (a) PEG-L-G micelles and (b) PEG-L-G/P nanoparticles in the presence of polymer P, wherein the polymer P stabilizes the PEG-L-G/P nanoparticles, in aqueous medium
Implementation Method 2
wherein the polymer P stabilizes the PEG-L-G/P nanoparticles
Data Source
AI summary
This disclosure relates to polyethylene glycol (PEG)-functionalized nanoparticles comprising a functional agent, and preparation methods, properties and applications thereof. The nanoparticle represented by PEG-L-G/P, comprising a type of hydrophilic PEG, a hydrophobic functional agent G, which are covalently linked by L: a linker or a chemical bond, and a type of hydrophobic polymer P. The G and P form the hydrophobic core, while the PEG constitutes the hydrophilic outer layer of the nanoparticle in an aqueous medium. The functional agent comprises one or more functional compounds including a therapeutic drug, an imaging diagnostic agent, a photoelectric responsive diagnostic agent, an immune-stimulating agent, or a combination thereof. The nanoparticles comprising such functional agent can offer various applications in multiple biomedical fields.